Literature DB >> 27326313

Mechanisms of adaptation of the hepatic vasculature to the deteriorating conditions of blood circulation in liver cirrhosis.

Dmitry Victorovich Garbuzenko1, Nikolay Olegovich Arefyev1, Dmitry Vladimirovich Belov1.   

Abstract

PubMed, EMBASE, Orphanet, MIDLINE, Google Scholar and Cochrane Library were searched for articles published between 1983 and 2015. Relevant articles were selected by using the following terms: "Liver cirrhosis", "Endothelial dysfunction", "Sinusoidal remodeling", "Intrahepatic angiogenesis" and "Pathogenesis of portal hypertension". Then the reference lists of identified articles were searched for other relevant publications as well. Besides gross hepatic structural disorders related to diffuse fibrosis and formation of regenerative nodules, the complex morphofunctional rearrangement of the hepatic microvascular bed and intrahepatic angiogenesis also play important roles in hemodynamic disturbances in liver cirrhosis. It is characterized by endothelial dysfunction and impaired paracrine interaction between activated stellate hepatocytes and sinusoidal endotheliocytes, sinusoidal remodeling and capillarization, as well as development of the collateral microcirculation. In spite of the fact that complex morphofunctional rearrangement of the hepatic microvascular bed and intrahepatic angiogenesis in liver cirrhosis are the compensatory-adaptive reaction to the deteriorating conditions of blood circulation, they contribute to progression of disease and development of serious complications, in particular, related to portal hypertension.

Entities:  

Keywords:  Endothelial dysfunction; Intrahepatic angiogenesis; Liver cirrhosis; Pathogenesis of portal hypertension; Sinusoidal remodeling

Year:  2016        PMID: 27326313      PMCID: PMC4909428          DOI: 10.4254/wjh.v8.i16.665

Source DB:  PubMed          Journal:  World J Hepatol


  55 in total

Review 1.  Innervation of the sinusoidal wall: regulation of the sinusoidal diameter.

Authors:  Takato Ueno; Paulette Bioulac-Sage; Charles Balabaud; Jean Rosenbaum
Journal:  Anat Rec A Discov Mol Cell Evol Biol       Date:  2004-09

2.  Endothelial HIF-2α regulates murine pathological angiogenesis and revascularization processes.

Authors:  Nicolas Skuli; Amar J Majmundar; Bryan L Krock; Rickson C Mesquita; Lijoy K Mathew; Zachary L Quinn; Anja Runge; Liping Liu; Meeri N Kim; Jiaming Liang; Steven Schenkel; Arjun G Yodh; Brian Keith; M Celeste Simon
Journal:  J Clin Invest       Date:  2012-03-19       Impact factor: 14.808

3.  Overexpression of angiopoietin-2 in rats and patients with liver fibrosis. Therapeutic consequences of its inhibition.

Authors:  Montse Pauta; Jordi Ribera; Pedro Melgar-Lesmes; Gregori Casals; Juan Rodríguez-Vita; Vedrana Reichenbach; Guillermo Fernandez-Varo; Blai Morales-Romero; Ramon Bataller; Javier Michelena; Jose Altamirano; Wladimiro Jiménez; Manuel Morales-Ruiz
Journal:  Liver Int       Date:  2014-03-11       Impact factor: 5.828

Review 4.  The scarring of the liver acini (Cirrhosis). Tridimensional and microcirculatory considerations.

Authors:  A M Rappaport; P J MacPhee; M M Fisher; M J Phillips
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

5.  Hypoxia and proinflammatory factors upregulate apelin receptor expression in human stellate cells and hepatocytes.

Authors:  Pedro Melgar-Lesmes; Montserrat Pauta; Vedrana Reichenbach; Gregori Casals; Josefa Ros; Ramon Bataller; Manuel Morales-Ruiz; Wladimiro Jiménez
Journal:  Gut       Date:  2011-03-29       Impact factor: 23.059

6.  Angiostatin and endostatin inhibit endothelial cell migration in response to FGF and VEGF without interfering with specific intracellular signal transduction pathways.

Authors:  Kerstin Eriksson; Peetra Magnusson; Johan Dixelius; Lena Claesson-Welsh; Michael J Cross
Journal:  FEBS Lett       Date:  2003-02-11       Impact factor: 4.124

Review 7.  Chemokines in liver inflammation and fibrosis.

Authors:  Fabio Marra
Journal:  Front Biosci       Date:  2002-09-01

8.  Molecular pathophysiology of portal hypertension.

Authors:  Mercedes Fernandez
Journal:  Hepatology       Date:  2015-03-09       Impact factor: 17.425

Review 9.  Angiogenesis: an organizing principle for drug discovery?

Authors:  Judah Folkman
Journal:  Nat Rev Drug Discov       Date:  2007-04       Impact factor: 84.694

Review 10.  PDGF and vessel maturation.

Authors:  Carina Hellberg; Arne Ostman; C-H Heldin
Journal:  Recent Results Cancer Res       Date:  2010
View more
  13 in total

1.  Bone marrow endothelial progenitor cells activate hepatic stellate cells and aggravate carbon tetrachloride induced liver fibrosis in mice via paracrine factors.

Authors:  Manali Garg; Savneet Kaur; Arpita Banik; Vikash Kumar; Archana Rastogi; Shiv K Sarin; Asok Mukhopadhyay; Nirupma Trehanpati
Journal:  Cell Prolif       Date:  2017-07-06       Impact factor: 6.831

2.  Anatomically and physiologically informed computational model of hepatic contrast perfusion for virtual imaging trials.

Authors:  Thomas J Sauer; Ehsan Abadi; Paul Segars; Ehsan Samei
Journal:  Med Phys       Date:  2022-03-20       Impact factor: 4.506

3.  Clinical perspective on the use of human amniotic epithelial cells to treat congenital metabolic diseases with a focus on maple syrup urine disease.

Authors:  Chika Takano; Brendan H Grubbs; Mika Ishige; Erika Ogawa; Ichiro Morioka; Satoshi Hayakawa; Toshio Miki
Journal:  Stem Cells Transl Med       Date:  2021-02-06       Impact factor: 6.940

Review 4.  Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma.

Authors:  Massimiliano Berretta; Luca Rinaldi; Fabrizio Di Benedetto; Arben Lleshi; Vallì De Re; Gaetano Facchini; Paolo De Paoli; Raffaele Di Francia
Journal:  Front Pharmacol       Date:  2016-11-09       Impact factor: 5.810

Review 5.  Restructuring of the vascular bed in response to hemodynamic disturbances in portal hypertension.

Authors:  Dmitry Victorovich Garbuzenko; Nikolay Olegovich Arefyev; Dmitry Vladimirovich Belov
Journal:  World J Hepatol       Date:  2016-12-28

Review 6.  Pathological process of liver sinusoidal endothelial cells in liver diseases.

Authors:  Yao Ni; Juan-Mei Li; Ming-Kun Liu; Ting-Ting Zhang; Dong-Ping Wang; Wen-Hui Zhou; Ling-Zi Hu; Wen-Liang Lv
Journal:  World J Gastroenterol       Date:  2017-11-21       Impact factor: 5.742

7.  Adenoviral‑bone morphogenetic protein‑7 and/or doxazosin therapies promote the reversion of fibrosis/cirrhosis in a cirrhotic hamster model.

Authors:  Daniel Cervantes-Garcia; Adriana Guadalupe Cuellar-Juarez; Gissela Borrego-Soto; Augusto Rojas-Martinez; Liseth Rubi Aldaba-Muruato; Eva Salinas; Javier Ventura-Juarez; Martin Humberto Muñoz-Ortega
Journal:  Mol Med Rep       Date:  2017-10-12       Impact factor: 2.952

8.  Evaluation of Hepatoprotective Effect of Curcumin on Liver Cirrhosis Using a Combination of Biochemical Analysis and Magnetic Resonance-Based Electrical Conductivity Imaging.

Authors:  Eun Jung Kyung; Hyun Bum Kim; Eun Sang Hwang; Seok Lee; Bup Kyung Choi; Jin Woong Kim; Hyung Joong Kim; Sang Moo Lim; Oh In Kwon; Eung Je Woo
Journal:  Mediators Inflamm       Date:  2018-05-17       Impact factor: 4.711

9.  Ligand Activation of PPARγ by Ligustrazine Suppresses Pericyte Functions of Hepatic Stellate Cells via SMRT-Mediated Transrepression of HIF-1α.

Authors:  Feng Zhang; Shuai Lu; Jianlin He; Huanhuan Jin; Feixia Wang; Li Wu; Jiangjuan Shao; Anping Chen; Shizhong Zheng
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

10.  Carvedilol Ameliorates Intrahepatic Angiogenesis, Sinusoidal Remodeling and Portal Pressure in Cirrhotic Rats.

Authors:  Liping Ling; Guangqi Li; Dongxiao Meng; Sining Wang; Chunqing Zhang
Journal:  Med Sci Monit       Date:  2018-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.